Rifampin Similar to Isoniazid for Preventing Active Tuberculosis
Rifampin has significantly higher rate of treatment completion, fewer drug-related adverse events
How Doctors Receive Feedback Is Key for Antimicrobial Programs
For inpatient providers, disagreement about antimicrobial use attribution rises with complexity
New Short-Term Health Plans Have Large Coverage Gaps
Plans don't have to cover existing medical conditions, provide limited benefits
Health Affairs Announces Launch of New Three-Year Initiative
Council on Health Care Spending and Value will be co-chaired by William Frist and Margaret Hamburg
New Ebola Outbreak in Congo
Currently, 26 suspected cases of Ebola, including 20 deaths
July 2018 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for July 2018. This roundup includes the latest...
Evidence Exists for Persistence, Transmission of Ebola Virus
Outbreak report describes transmission of Ebola virus one year after survival of Ebola virus disease
Protease Inhibitors May Worsen Outcomes for HIV + Heart Failure
Higher rates seen for hyperlipidemia, diabetes, coronary artery disease, cardiovascular mortality
Tamsulosin Does Not Appear to Promote Urinary Stone Passage
Findings do not support tamsulosin treatment for symptomatic urinary stones <9 mm
National Guideline Clearinghouse Offline Due to Funding Cuts
An initiative of AHRQ, guideline.gov now offline due to lack of federal funding
